CAPTOPRIL IN THE TREATMENT OF CLINICAL HYPERTENSION AND CARDIAC FAILURE

@article{Atkinson1979CAPTOPRILIT,
  title={CAPTOPRIL IN THE TREATMENT OF CLINICAL HYPERTENSION AND CARDIAC FAILURE},
  author={Anthony B. Atkinson and J. Ian S. Robertson},
  journal={The Lancet},
  year={1979},
  volume={314},
  pages={836-839}
}
View on Elsevier
doi.org
370 Citations
Highly Influential Citations
5
Background Citations
47
Methods Citations
3
Results Citations
1

370 Citations

Inflammatory nephrocutaneous diseases including associated cutaneous and renal manifestations and referral considerations Disease Cutaneous findings Renal findings

This review discusses important nephrocutaneous disease associations and recommendations for the appropriate urgency of referral to nephrology colleagues for diagnosis, surveillance, and early management of potential renal sequelae.

Analytical strategies for the characterization, identification, and quantification of peptides and proteins of interest in the prevention and understanding of hypertension

La hipertension constituye un serio problema de salud y esta considerada como una de las causas de las enfermedades cardiovasculares y renales. A pesar de la prevalencia de la hipertension, la mitad…

Seasonal variation in nitrogenous components and bioactivity of protein hydrolysates from Porphyra dioica

The results demonstrate the potential of P. dioica hydrolysates as health-enhancing food components or natural food preservatives due to their enzyme inhibitory and antioxidant activities.

Angiotensin-I-converting enzyme and prolyl endopeptidase inhibitory peptides from marine processing by-products

Combination Therapy with Paricalcitol and Enalapril Ameliorates Cardiac Oxidative Injury in Uremic Rats

Treatment with enalapril, paricalcitol or the combination of the two protected uremic rats from cardiac oxidative stress by inhibiting enzyme activity.

Pharmacological potential of seaweed-associated heterotrophic bacterium Bacillus atrophaeus

The heterotrophic B. atrophaeus SHB2097 could be used to develop potential therapeutic and biomedical agents and the significance of nuclear magnetic resonance-centered analyses of distinguishing signals in the organic extract and correlating those with bioactive potential was accentuated.

Hempseed (Cannabis sativa) protein hydrolysates: A valuable source of bioactive peptides with pleiotropic health-promoting effects

An exploration of ACE inhibitory peptides derived from gastrointestinal protease hydrolysate of milk using a modified bioassay-guided fractionation approach coupled with in silico analysis

An improved bioassay-guided fractionation was performed to effectively screen angiotensin-I converting enzyme inhibitory (ACEI) peptides from milk protein hydrolysate. The aqueous normal phase liquid…

Isolation, identification, and molecular docking analysis of novel ACE inhibitory peptides from Spirulina platensis

Novel insights are provided for the development of ACE inhibitors and the high-value utilization of Spirulina platensis for blood pressure regulation and bioactive peptide production.

Antimicrobial Activity and Toxicity of Analogs of Wasp Venom EMP Peptides. Potential Influence of Oxidized Methionine

Only EMP-AF-OR showed concentration-dependent growth inhibition against all bacterial species tested, and the hemolytic activity of the analogs were moderated though reports of the natural peptides, especially EMP-af-OR, already showed low toxicity against erythrocytes.
...

References

SHOWING 1-10 OF 60 REFERENCES

Book Review: Mild Hypertension: Natural History and Management

NEPHROTIC SYNDROME IN PATIENT ON

Mechanism of blood pressure reduction by teprotide (SQ 20881) in rats.

Teprotide did not appear to exert its hypotensive effect by any mechanism other than inhibition of the renin-angiotensin system and given at a maximally effective dose to the rat, it produced no greater vasodepressor effect than did saralasin.

Increased glomerular filtration rate after converting-enzyme inhibition in essential hypertension.

Observations suggest that a functional element, perhaps involving angiotensin-mediated renal vasoconstriction, frequently has a role in the reduction in glomerular filtration rate that occurs in essential hypertension, which may improve renal excretory function as it controls hypertension.

Design of specific inhibitors of angiotensin-converting enzyme: new class of orally active antihypertensive agents.

A hypothetical model of the active site of angiotensin-converting enzyme, based on known chemical and kinetic properties of the enzyme, has enabled a new class of potent and specific inhibitors, carboxyalkanoyl and mercaptoalkanoysl derivatives of proline, to be designed.

Reversible renal failure during treatment with captopril.

INNAPPROPRIATE RENIN SECRETION UNMASKED BY CAPTOPRIL (SQ 14 225) IN HYPERTENSION OF CHRONIC RENAL FAILURE

A slowly developing pressor response to small concentrations of angiotensin. Its bearing on the pathogenesis of chronic renal hypertension.

SQ 14,225 (D-3-mercapto-2-methylpropanoyl-l-proline), a novel orally active inhibitor of angiotensin I-converting enzyme.

Captopril (SQ 14,225) (D-3-mercapto-2-methylpropranoyl-L-proline): a novel orally active inhibitor of angiotensin-converting enzyme and antihypertensive agent.

...